Calculus, a leading provider of tax efficient investments, today announced the appointment of Elizabeth Klein as Investment Director starting today (31st October 2022). 

Ms. Klein is a seasoned investment management, direct investment, and deal origination expert. She will help lead Calculus with its strategy to build diversified portfolios, utilising her network and relationships to generate deal flow, predominantly in the Life Sciences sector. 

Ms. Klein brings a wealth of experience to the role having advised C-suite level executives in several organisations on their investment and funding strategies and has helped them to build transformational relationships with the UK Life Sciences community network.

Commenting on the appointment, John Glencross, CEO and Founder of Calculus, said: “It’s a real coup to have someone of Elizabeth’s expertise and reputation join Calculus at such a pivotal time for the industry.

“Her breadth of knowledge, agility, and impressive network will undoubtedly be a key factor to our success in the coming months as we strive to help smaller, entrepreneurial growth companies scale-up, as well as creating value for our investors.

Click here to read the full article 



020 7071 3945


Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.